03232017Headline:

Expansion is the key strategy adopted by major players in the superdisintegrants market

The superdisintegrants market is characterized by the presence of large as well as small players operating at global and regional levels. The major five players of this market accounted for around 53% share of the global superdisintegrants market in 2015. Most of the key players in this market are based in developed countries across North America and Europe. Some of the leading players in this market include Ashland, Inc. (U.S.), BASF SE (Germany), FMC Corporation (U.S.), JRS Pharma (Germany), DFE Pharma (Germany).

Ashland, Inc. (U.S.) led the superdisintegrants market in 2015. This is majorly attributed to its strong manufacturing and distribution capabilities, which enable it to serve customers in more than 100 countries globally. The company offers crospovidone, which is the largest market for superdisintegrants. In order to gain a competitive edge in this market, the company focuses on organic growth strategies such as expansions. For instance, in September 2014, Ashland opened a new pharmaceutical center of excellence in Wilmington, U.S. The new facility focuses on drug development and bioavailability enhancement of pharmaceutical drugs. It also focuses on business reconstruction to stabilize its financial growth, through focus on individual businesses

BASF SE (Germany) was the second leading company of the superdisintegrants market in 2015. This is majorly attributed to its innovative product portfolio and strong relationships with its customers.  By 2020, the company plans to conduct around 25% of its R&D activities in the Asia-Pacific region, to develop innovative solutions to address the region’s challenges of resource efficiency, food, and nutrition. The company also focuses on inorganic strategies such as expansions and collaborations in order to grow in this market.  For instance, in November 2015, the company established the BASF Innovation Campus Asia Pacific (Shanghai). This establishment enabled the company to boost its research and development activities for the healthcare industry, and enabled it to work in close association with its customers in the APAC region.

Expansion was the key strategy adopted by major players in the superdisintegrants market from 2013 to 2016. Expansions have enabled companies in increasing their customer base, meeting the growing demands of the emerging markets better, and in greater market penetration, ensuring long-term revenue generation.

What Next?

Recent Articles